Introduction In the business context, we refer to “deal landscape” as the overall environment and conditions in which business deals, particularly mergers and acquisitions – M&A, take place. It encompasses the various factors that influence deal-making, such as the types of deals being made, the stakeholders involved, the availability of attractive assets on the market,…
Details
2023 is about to end and it was a significant year for healthcare as the industry shifted its focus towards previously overlooked areas. Although many of these issues are still being addressed, the COVID-19 pandemic also served as a turning point for the healthcare industry to transform itself and seize opportunities that can positively impact…
Details
A go-to-market (GTM) strategy is a comprehensive plan that includes all the actions required to effectively launch a product or service and generate the intended effects. The main components of a good GTM strategy usually are: What is the difference between GTM and Marketing mix? The strategy for providing and advertising a product or service…
Details
The medical device and healthtech products market is growing faster than any other segment of the healthcare industry. In fact, it’s expected to double in size by 2025, accounting for 10% of all healthcare spending that year. We also see more and more healthcare startups launching new medical products every day. They’re a sign of…
Details
It is amazing how time flies, and here we are at the Jewish new year again. As one year ends and we transition into another, we take this opportunity to send our wishes for a sweet, healthy and successful new year to all of our partners, colleagues, clients and friends who are celebrating. Shana Tova…
Details
September, 2022 Aurore ANDRE, CEO of Azapharm joins the strategic board of Apmonia Therapeutics, a biotechnology company dedicated to developing anti-cancer immunotherapy strategies. Apmonia’s strategic board comprises experts in biotech, business, funding and more, who harness their experience to support the company’s innovation and growth. “I am pleased to welcome Aurore to our strategic board. We believe the experience and knowledge she brings…
Details
A recent article, posted on Linkedin by Aurore Andre, CEO of Azapharm reviews the use of Artificial Intelligence in healthcare: pros, cons and the path forward. Artificial intelligence is one of the fastest-growing industries, with sector funding up by 108% in 2021. Among those investments and developments are applications for medical care and hospital administration.…
Details
By: Katherine Wong-Selz Overview of the Horizon Europe Programme At the beginning of April, the European Commission launched the first calls for the Horizon Europe programme. Between now and 2027, it will provide nearly 100 billion € in research and innovation project funding to boost Europe’s research excellence and transform the fruits of that excellence…
Details
It’s been a challenging year for everyone, but as the Beatles said “Here comes the sun, and I say it’s all right”. As we’re getting ready to celebrate Passover, the holiday of spring and freedom, we wish you and your loved ones a great break to recharge, regenerate and returned filled with hope. From all…
Details
Digital Communication for Healthtech MedTech and Biotech companies: How things have changed and will change this year Digital communication is never as easy as it sounds. It’s not all about social media and content marketing. It is not about your website and the newsletters you send. These are all just tools. Digital communication is first…
Details